Literature DB >> 2402302

Effect of nicotine and tacrine on acetylcholine release from rat cerebral cortical slices.

R E Loiacono1, F J Mitchelson.   

Abstract

The effect of nicotine (1-10 microM) and tacrine (9-amino-1,2,3,4-tetrahydroacridine; THA) on stimulation evoked release of [3H]acetylcholine from the rat brain slice preparation preincubated with [3H]choline was investigated. In these preparations, nicotine enhanced while tacrine inhibited evoked [3H]acetylcholine release. These effects were blocked by (+)tubocurarine (1 microM) and atropine (0.1 microM) respectively. In the presence of idazoxan (0.3 microM) plus atropine (0.1 microM), nicotine (3 microM) continued to enhance evoked [3H]acetylcholine release while the inhibitory effect of tacrine (1 microM) on evoked [3H]acetylcholine release was reversed to an enhancement. Under these circumstances the effects of both nicotine and tacrine were blocked by (+)tubocurarine (1 microM). These findings demonstrate that tacrine can both inhibit or enhance [3H]acetylcholine release, most likely through its activity as a cholinesterase inhibitor. Under normal circumstances following tacrine the predominant effect of the elevated levels of acetylcholine will be activation of inhibitory presynaptic muscarine receptors on cholinergic nerves and an inhibition of evoked [3H]acetylcholine release. Under conditions where both presynaptic inhibitory muscarine and alpha 2-adrenoceptors are blocked, the elevated levels of acetylcholine produced by tacrine will lead to the activation of facilitatory presynaptic nicotine cholinoceptors on cholinergic nerves and an enhancement of evoked [3H]acetylcholine release.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2402302     DOI: 10.1007/bf00178968

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

1.  Tacrine in Alzheimer's disease.

Authors:  B Davies; D Andrewes; R Stargatt; D Ames; V Tuckwell; S Davis
Journal:  Lancet       Date:  1989-07-15       Impact factor: 79.321

2.  Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors.

Authors:  L T Potter; C A Ferrendelli; H E Hanchett; M A Hollifield; M V Lorenzi
Journal:  Mol Pharmacol       Date:  1989-05       Impact factor: 4.436

3.  Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors?

Authors:  L Nilsson; A Adem; J Hardy; B Winblad; A Nordberg
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

4.  Nicotinic stimulation of [3H]acetylcholine release from mouse cerebral cortical synaptosomes.

Authors:  P P Rowell; D L Winkler
Journal:  J Neurochem       Date:  1984-12       Impact factor: 5.372

5.  [3H]acetylcholine release from the phrenic nerve is increased or decreased by activation or desensitization of nicotine receptors.

Authors:  I Wessler; B Scheuer; H Kilbinger
Journal:  Eur J Pharmacol       Date:  1987-03-03       Impact factor: 4.432

6.  [3H]acetylcholine and [3H](-)nicotine label the same recognition site in rat brain.

Authors:  A M Martino-Barrows; K J Kellar
Journal:  Mol Pharmacol       Date:  1987-02       Impact factor: 4.436

7.  Different approaches to study acetylcholine release: endogenous ACh versus tritium efflux.

Authors:  L Beani; C Bianchi; A Siniscalchi; L Sivilotti; S Tanganelli; E Veratti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

8.  3H-nicotine- and 125I-alpha-bungarotoxin-labeled nicotinic receptors in the interpeduncular nucleus of rats. II. Effects of habenular deafferentation.

Authors:  P B Clarke; G S Hamill; N S Nadi; D M Jacobowitz; A Pert
Journal:  J Comp Neurol       Date:  1986-09-15       Impact factor: 3.215

9.  Characterization of L-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal.

Authors:  D D Flynn; D C Mash
Journal:  J Neurochem       Date:  1986-12       Impact factor: 5.372

Review 10.  Clinical experience with and side-effects of tacrine hydrochloride in Alzheimer's disease: a pilot study.

Authors:  D R Forsyth; D J Surmon; R A Morgan; G K Wilcock
Journal:  Age Ageing       Date:  1989-07       Impact factor: 10.668

View more
  3 in total

1.  No involvement of nicotinic receptors in the facilitation of acetylcholine outflow in mouse cortex in the presence of neostigmine and atropine.

Authors:  L Iannazzo; H Majewski
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

2.  Effects of nicotine receptor agonists on acetylcholine release from the isolated motor nerve, small intestine and trachea of rats and guinea-pigs.

Authors:  I Wessler; C Apel; M Garmsen; A Klein
Journal:  Clin Investig       Date:  1992 Mar-Apr

Review 3.  Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.

Authors:  A J Wagstaff; D McTavish
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.